Alpha7 nicotinic‐N‐methyl‐D‐aspartate hypothesis in the treatment of schizophrenia and beyond
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Alpha7 nicotinic‐N‐methyl‐D‐aspartate hypothesis in the treatment of schizophrenia and beyond
Authors
Keywords
-
Journal
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-09-23
DOI
10.1002/hup.2758
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ‘That’s the Esketamine, Baby, there’s Nothing You Can Do about It!’ An Update on Glutamatergic System in Suicidal Depression
- (2020) Domenico De Berardis et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Effects of inflammation on the kynurenine pathway in schizophrenia — a systematic review
- (2020) Bruno Pedraz-Petrozzi et al. Journal of Neuroinflammation
- Double blind, two dose, randomized, placebo-controlled, cross-over clinical trial of the positive allosteric modulator at the alpha7 nicotinic cholinergic receptor AVL-3288 in schizophrenia patients
- (2020) Joshua T. Kantrowitz et al. NEUROPSYCHOPHARMACOLOGY
- Potential Roles of Redox Dysregulation in the Development of Schizophrenia
- (2020) Diana O. Perkins et al. BIOLOGICAL PSYCHIATRY
- Proof of mechanism and target engagement of glutamatergic drugs for the treatment of schizophrenia: RCTs of pomaglumetad and TS-134 on ketamine-induced psychotic symptoms and pharmacoBOLD in healthy volunteers
- (2020) Joshua T. Kantrowitz et al. NEUROPSYCHOPHARMACOLOGY
- Antidepressant-like effects of kynurenic acid in a modified forced swim test
- (2020) Masaru Tanaka et al. Pharmacological Reports
- Activation of alpha7 nicotinic and NMDA receptors is necessary for performance in a working memory task
- (2020) David Phenis et al. PSYCHOPHARMACOLOGY
- α7 nicotinic acetylcholine receptors as therapeutic targets in schizophrenia: Update on animal and clinical studies and strategies for the future
- (2020) Alvin V. Terry et al. NEUROPHARMACOLOGY
- Meta-analysis of randomized controlled trials of galantamine in schizophrenia: significant cognitive enhancement
- (2020) Maju Mathew Koola et al. PSYCHIATRY RESEARCH
- Synapse-to-nucleus signaling in neurodegenerative and neuropsychiatric disorders
- (2019) Arnaldo Parra-Damas et al. BIOLOGICAL PSYCHIATRY
- Cognitive Enhancer Effects of Low Memantine Doses Are Facilitated by an Alpha7 Nicotinic Acetylcholine Receptor Agonist in Scopolamine-Induced Amnesia in Rats
- (2019) Zsolt Kristóf Bali et al. Frontiers in Pharmacology
- A Genetics Perspective on the Role of the (Neuro)Immune System in Schizophrenia
- (2019) Rebecca Birnbaum et al. SCHIZOPHRENIA RESEARCH
- The kynurenine pathway: a finger in every pie
- (2019) Jonathan Savitz MOLECULAR PSYCHIATRY
- Synthesis and in vivo evaluation of [18F]UCB-J for PET imaging of synaptic vesicle glycoprotein 2A (SV2A)
- (2019) Songye Li et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Adjunctive minocycline for major mental disorders: A systematic review
- (2019) Wei Zheng et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Adjunctive memantine for major mental disorders: A systematic review and meta-analysis of randomized double-blind controlled trials
- (2019) Wei Zheng et al. SCHIZOPHRENIA RESEARCH
- Lower synaptic density is associated with depression severity and network alterations
- (2019) Sophie E. Holmes et al. Nature Communications
- Facilitation and inhibition of firing activity and N-methyl-D-aspartate-evoked responses of CA1 hippocampal pyramidal cells by alpha7 nicotinic acetylcholine receptor selective compounds in vivo
- (2019) Zsolt Kristóf Bali et al. Scientific Reports
- Early Detection and Preventive Intervention in Schizophrenia: From Fantasy to Reality
- (2019) Jeffrey A. Lieberman et al. AMERICAN JOURNAL OF PSYCHIATRY
- In vivo imaging of synaptic loss in Alzheimer’s disease with [18F]UCB-H positron emission tomography
- (2019) Christine Bastin et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Toward a paradigm shift in treatment and research of mental disorders
- (2019) Falk Leichsenring et al. PSYCHOLOGICAL MEDICINE
- An update on the efficacy of anti-inflammatory agents for patients with schizophrenia: a meta-analysis
- (2019) N. Çakici et al. PSYCHOLOGICAL MEDICINE
- Kynurenines and the Endocannabinoid System in Schizophrenia: Common Points and Potential Interactions
- (2019) Ferenc Zádor et al. MOLECULES
- Influence of combined treatment with naltrexone and memantine on alcohol drinking behaviors: a phase II randomized crossover trial
- (2019) Suchitra Krishnan-Sarin et al. NEUROPSYCHOPHARMACOLOGY
- Memantine treatment prevents okadaic acid induced neurotoxicity at the systemic and molecular levels
- (2019) Manana G. Dashniani et al. NEUROREPORT
- Varenicline for cognitive impairment in people with schizophrenia: systematic review and meta-analysis
- (2019) Timothy Tanzer et al. PSYCHOPHARMACOLOGY
- Functional characterization of α7 nicotinic acetylcholine and NMDA receptor signaling in SH-SY5Y neuroblastoma cells in an ERK phosphorylation assay
- (2018) Mohamed R. Elnagar et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Anti-Dementia Drugs for Psychopathology and Cognitive Impairment in Schizophrenia: A Systematic Review and Meta-Analysis
- (2018) Taro Kishi et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Galantamine and Computerized Cognitive Behavioral Therapy for Cocaine Dependence
- (2018) Kathleen M. Carroll et al. JOURNAL OF CLINICAL PSYCHIATRY
- The past and future of novel, non-dopamine-2 receptor therapeutics for schizophrenia: A critical and comprehensive review
- (2018) Ragy R. Girgis et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Synaptic loss in schizophrenia: a meta-analysis and systematic review of synaptic protein and mRNA measures
- (2018) Emanuele Felice Osimo et al. MOLECULAR PSYCHIATRY
- Convergence of placenta biology and genetic risk for schizophrenia
- (2018) Gianluca Ursini et al. NATURE MEDICINE
- Role of α7nAChR-NMDAR in sevoflurane-induced memory deficits in the developing rat hippocampus
- (2018) XiaoHong Tang et al. PLoS One
- Utility of Imaging-Based Biomarkers for Glutamate-Targeted Drug Development in Psychotic Disorders
- (2018) Daniel C. Javitt et al. JAMA Psychiatry
- Additive Dose Response Models: Explicit Formulation and the Loewe Additivity Consistency Condition
- (2018) Simone Lederer et al. Frontiers in Pharmacology
- The application of positron emission tomography (PET) imaging in CNS drug development
- (2018) Ivonne Suridjan et al. Brain Imaging and Behavior
- Network Analysis Reveals the Latent Structure of Negative Symptoms in Schizophrenia
- (2018) Gregory P Strauss et al. SCHIZOPHRENIA BULLETIN
- Effects of 12-month, double-blind N-acetyl cysteine on symptoms, cognition and brain morphology in early phase schizophrenia spectrum disorders
- (2018) Alan Breier et al. SCHIZOPHRENIA RESEARCH
- Multi-Target Approach for Drug Discovery against Schizophrenia
- (2018) Magda Kondej et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Maternal genotype determines kynurenic acid levels in the fetal brain: Implications for the pathophysiology of schizophrenia
- (2018) Sarah Beggiato et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The effect of minocycline on symptoms in schizophrenia: Results from a randomized controlled trial
- (2018) Mark Weiser et al. SCHIZOPHRENIA RESEARCH
- Herpes simplex virus 1 infection and valacyclovir treatment in schizophrenia: Results from the VISTA study
- (2018) Alan Breier et al. SCHIZOPHRENIA RESEARCH
- Can N‑acetylcysteine, varenicline, or the combination prevent psychosis by enhancing mismatch negativity?
- (2018) Maju Mathew Koola SCHIZOPHRENIA RESEARCH
- The Meaning of Glutamate and the Quest for Biomarkers in the Transition to Psychosis
- (2018) Juan R. Bustillo et al. JAMA Psychiatry
- Treating the Synapse in Major Psychiatric Disorders: The Role of Postsynaptic Density Network in Dopamine-Glutamate Interplay and Psychopharmacologic Drugs Molecular Actions
- (2017) Carmine Tomasetti et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Theranostic Biomarkers for Schizophrenia
- (2017) Matea Perkovic et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A Randomized Clinical Trial of Oxytocin or Galantamine for the Treatment of Negative Symptoms and Cognitive Impairments in People With Schizophrenia
- (2017) Robert W. Buchanan et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Investigating the neuroimmunogenic architecture of schizophrenia
- (2017) R Birnbaum et al. MOLECULAR PSYCHIATRY
- The need for new approaches in CNS drug discovery: Why drugs have failed, and what can be done to improve outcomes
- (2017) Valentin K. Gribkoff et al. NEUROPHARMACOLOGY
- Elevated kynurenine pathway metabolism during neurodevelopment: Implications for brain and behavior
- (2017) Francesca M. Notarangelo et al. NEUROPHARMACOLOGY
- Deconstructing Schizophrenia
- (2017) William T. Carpenter NEUROPSYCHOBIOLOGY
- Neuroprotective Effects of Galantamine on Nerve Agent-Induced Neuroglial and Biochemical Changes
- (2017) RamaRao Golime et al. NEUROTOXICITY RESEARCH
- Synthesis, radiolabeling and preclinical evaluation of a [ 11 C]GMOM derivative as PET radiotracer for the ion channel of the N-methyl-D-aspartate receptor
- (2017) Pieter J. Klein et al. NUCLEAR MEDICINE AND BIOLOGY
- Treatment effects between monotherapy of donepezil versus combination with memantine for Alzheimer disease: A meta-analysis
- (2017) Ruey Chen et al. PLoS One
- New drug developments in psychosis: Challenges, opportunities and strategies
- (2017) Matcheri S. Keshavan et al. PROGRESS IN NEUROBIOLOGY
- N-acetylcysteine in a Double-Blind Randomized Placebo-Controlled Trial: Toward Biomarker-Guided Treatment in Early Psychosis
- (2017) Philippe Conus et al. SCHIZOPHRENIA BULLETIN
- Future of Days Past: Neurodevelopment and Schizophrenia
- (2017) Daniel R Weinberger SCHIZOPHRENIA BULLETIN
- Alpha7 Nicotinic Acetylcholine Receptors Play a Predominant Role in the Cholinergic Potentiation of N-Methyl-D-Aspartate Evoked Firing Responses of Hippocampal CA1 Pyramidal Cells
- (2017) Zsolt K. Bali et al. Frontiers in Cellular Neuroscience
- Kynurenine pathway in schizophrenia: Galantamine-memantine combination for cognitive impairments
- (2017) Maju Mathew Koola et al. SCHIZOPHRENIA RESEARCH
- Interactive effects of an N-methyl-d-aspartate receptor antagonist and a nicotinic acetylcholine receptor agonist on mismatch negativity: Implications for schizophrenia
- (2017) Holly K. Hamilton et al. SCHIZOPHRENIA RESEARCH
- The combination of memantine and galantamine improves cognition in rats: The synergistic role of the α7 nicotinic acetylcholine and NMDA receptors
- (2016) Agnieszka Nikiforuk et al. BEHAVIOURAL BRAIN RESEARCH
- Synaptic interactions and inhibitory regulation in auditory cortex
- (2016) Caitlin E. Askew et al. BIOLOGICAL PSYCHOLOGY
- Repurposing Drugs for Cognition in Schizophrenia
- (2016) YS Yang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- D-cycloserine in Schizophrenia: New Strategies for Improving Clinical Outcomes by Enhancing Plasticity
- (2016) Donald Goff Current Neuropharmacology
- Targeting Functional Biomarkers in Schizophrenia with Neuroimaging
- (2016) Korey P. Wylie et al. CURRENT PHARMACEUTICAL DESIGN
- Restraint Stress during Pregnancy Rapidly Raises Kynurenic Acid Levels in Mouse Placenta and Fetal Brain
- (2016) Francesca M. Notarangelo et al. DEVELOPMENTAL NEUROSCIENCE
- Cross-talk between α7 nAchR and NMDAR revealed by protein profiling
- (2016) Hailong Zhang et al. Journal of Proteomics
- The search for imaging biomarkers in psychiatric disorders
- (2016) Anissa Abi-Dargham et al. NATURE MEDICINE
- The 15q13.3 deletion syndrome: Deficient α7-containing nicotinic acetylcholine receptor-mediated neurotransmission in the pathogenesis of neurodevelopmental disorders
- (2016) Stephen I. Deutsch et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Elevated brain lactate in schizophrenia: a 7 T magnetic resonance spectroscopy study
- (2016) L M Rowland et al. Translational Psychiatry
- The multiple roles of the α7 nicotinic acetylcholine receptor in modulating glutamatergic systems in the normal and diseased nervous system
- (2015) Fani Koukouli et al. BIOCHEMICAL PHARMACOLOGY
- From the genetic architecture to synaptic plasticity in autism spectrum disorder
- (2015) Thomas Bourgeron NATURE REVIEWS NEUROSCIENCE
- The human CHRNA7 and CHRFAM7A genes: A review of the genetics, regulation, and function
- (2015) Melissa L. Sinkus et al. NEUROPHARMACOLOGY
- The Placenta as a Mediator of Stress Effects on Neurodevelopmental Reprogramming
- (2015) Stefanie L Bronson et al. NEUROPSYCHOPHARMACOLOGY
- Randomized, Double-Blind, Placebo-Controlled Study of Encenicline, an α7 Nicotinic Acetylcholine Receptor Agonist, as a Treatment for Cognitive Impairment in Schizophrenia
- (2015) Richard SE Keefe et al. NEUROPSYCHOPHARMACOLOGY
- Nicotinic ACh receptors as therapeutic targets in CNS disorders
- (2015) Kelly T. Dineley et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Contribution of NMDA receptors to dorsolateral prefrontal cortical networks in primates
- (2015) Min Wang et al. Neuroscience Bulletin
- The modulation of nicotinic acetylcholine receptors on the neuronal network oscillations in rat hippocampal CA3 area
- (2015) Yang Wang et al. Scientific Reports
- Cumulative, additive benefits of memantine-donepezil combination over component monotherapies in moderate to severe Alzheimer’s dementia: a pooled area under the curve analysis
- (2015) Alireza Atri et al. Alzheimers Research & Therapy
- Nicotinic modulation of glutamate receptor function at nerve terminal level: a fine-tuning of synaptic signals
- (2015) Mario Marchi et al. Frontiers in Pharmacology
- A double-blind, placebo-controlled comparator study of LY2140023 monohydrate in patients with schizophrenia
- (2014) AnnCatherine M Downing et al. BMC Psychiatry
- Potential Role of N-Acetylcysteine in the Management of Substance Use Disorders
- (2014) Erin A. McClure et al. CNS DRUGS
- Nicotinic acetylcholine receptors in human genetic disease
- (2014) Christian P. Schaaf GENETICS IN MEDICINE
- Normalizing Effects of EVP-6124, an Alpha-7 Nicotinic Partial Agonist, on Event-Related Potentials and Cognition
- (2014) SHELDON H. PRESKORN et al. Journal of Psychiatric Practice
- Cortical parvalbumin GABAergic deficits with α7 nicotinic acetylcholine receptor deletion: implications for schizophrenia
- (2014) Hong Lin et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Prolonged nicotine exposure down-regulates presynaptic NMDA receptors in dopaminergic terminals of the rat nucleus accumbens
- (2014) Alessia Salamone et al. NEUROPHARMACOLOGY
- A Randomized, Placebo-Controlled Study Investigating the Nicotinic α7 Agonist, RG3487, for Cognitive Deficits in Schizophrenia
- (2014) Daniel Umbricht et al. NEUROPSYCHOPHARMACOLOGY
- Potential role of the combination of galantamine and memantine to improve cognition in schizophrenia
- (2014) Maju Mathew Koola et al. SCHIZOPHRENIA RESEARCH
- An open-label pilot trial ofN-acetylcysteine and varenicline in adult cigarette smokers
- (2014) Erin A. McClure et al. AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE
- National Institute of Mental Health Clinical Trials
- (2014) Thomas R. Insel et al. JAMA Psychiatry
- The Use of Medications Approved for Alzheimer’s Disease in Autism Spectrum Disorder: A Systematic Review
- (2014) Daniel A. Rossignol et al. Frontiers in Pediatrics
- Biomarkers in psychosis: an approach to early identification and individualized treatment
- (2013) Heline Mirzakhanian et al. Biomarkers in Medicine
- The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disorders
- (2013) Trevor W Stone et al. BRITISH JOURNAL OF PHARMACOLOGY
- Nicotinic Receptors as Therapeutic Targets for Drug Addictive Disorders
- (2013) Shafiqur Rahman CNS & Neurological Disorders-Drug Targets
- Biomarkers in Schizophrenia: A Brief Conceptual Consideration
- (2013) Cynthia S. Weickert et al. DISEASE MARKERS
- Activation of α7-containing nicotinic receptors on astrocytes triggers AMPA receptor recruitment to glutamatergic synapses
- (2013) Xulong Wang et al. JOURNAL OF NEUROCHEMISTRY
- Deconstructing negative symptoms of schizophrenia: Avolition–apathy and diminished expression clusters predict clinical presentation and functional outcome
- (2013) Gregory P. Strauss et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid
- (2013) Zuzana Justinova et al. NATURE NEUROSCIENCE
- Cortical synaptic NMDA receptor deficits in α7 nicotinic acetylcholine receptor gene deletion models: Implications for neuropsychiatric diseases
- (2013) Hong Lin et al. NEUROBIOLOGY OF DISEASE
- A Randomized Exploratory Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) for Cognitive Enhancement in Schizophrenia
- (2013) Jeffrey A Lieberman et al. NEUROPSYCHOPHARMACOLOGY
- Two receptors are involved in the central functions of kynurenic acid under an acute stress in neonatal chicks
- (2013) J. Yoshida et al. NEUROSCIENCE
- Nicotinic 7 receptors enhance NMDA cognitive circuits in dorsolateral prefrontal cortex
- (2013) Y. Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Network beyond IDO in psychiatric disorders: Revisiting neurodegeneration hypothesis
- (2013) Aye-Mu Myint et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Relief of cannabis withdrawal symptoms and cannabis quitting strategies in people with schizophrenia
- (2013) Maju Mathew Koola et al. PSYCHIATRY RESEARCH
- α7nAchR/NMDAR coupling affects NMDAR function and object recognition
- (2013) Shupeng Li et al. Molecular Brain
- Galantamine potentiates the neuroprotective effect of memantine against NMDA-induced excitotoxicity
- (2013) João P. Lopes et al. Brain and Behavior
- Worldwide Alzheimer’s Disease Neuroimaging Initiative
- (2012) Maria C. Carrillo et al. Alzheimers & Dementia
- Early detection of neurodegenerative diseases
- (2012) Kira S. Sheinerman et al. CELL CYCLE
- Glutamatergic Synapse Formation is Promoted by 7-Containing Nicotinic Acetylcholine Receptors
- (2012) A. F. Lozada et al. JOURNAL OF NEUROSCIENCE
- A combination of galantamine and memantine modifies cognitive function in subjects with amnestic MCI
- (2012) Oliver Peters et al. Journal of Nutrition Health & Aging
- Synergistic Effects of Galantamine and Memantine in Attenuating Scopolamine-Induced Amnesia in Mice
- (2012) Perrine Busquet et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Alcohol and cannabis use and mortality in people with schizophrenia and related psychotic disorders
- (2012) Maju Mathew Koola et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Alpha7 nicotinic cholinergic neuromodulation may reconcile multiple neurotransmitter hypotheses of schizophrenia
- (2012) Merouane Bencherif et al. MEDICAL HYPOTHESES
- Preventing Alzheimer's Disease
- (2012) D. J. Selkoe SCIENCE
- Developing predictive CSF biomarkers—A challenge critical to success in Alzheimer's disease and neuropsychiatric translational medicine
- (2011) Dorothy G. Flood et al. BIOCHEMICAL PHARMACOLOGY
- Meta-Analysis of the Efficacy of Adjunctive NMDA Receptor Modulators in Chronic Schizophrenia
- (2011) Surendra P. Singh et al. CNS DRUGS
- Cooperation between cholinergic and glutamatergic receptors are essential to induce BDNF-dependent long-lasting memory storage
- (2011) Sheeja Navakkode et al. HIPPOCAMPUS
- A Multicenter, Inpatient, Phase 2, Double-Blind, Placebo-Controlled Dose-Ranging Study of LY2140023 Monohydrate in Patients With DSM-IV Schizophrenia
- (2011) Bruce J. Kinon et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Adjunctive Varenicline Treatment with Antipsychotic Medications for Cognitive Impairments in People with Schizophrenia: A Randomized Double-Blind Placebo-Controlled Trial
- (2011) Joo-Cheol Shim et al. NEUROPSYCHOPHARMACOLOGY
- Glutamate and nicotinic receptor interactions in working memory: importance for the cognitive impairment of schizophrenia
- (2011) O.A. Timofeeva et al. NEUROSCIENCE
- On the antioxidant properties of kynurenic acid: Free radical scavenging activity and inhibition of oxidative stress
- (2011) R. Lugo-Huitrón et al. NEUROTOXICOLOGY AND TERATOLOGY
- Cholinergic hypofunction impairs memory acquisition possibly through hippocampal Arc and BDNF downregulation
- (2010) Francisco J. Gil-Bea et al. HIPPOCAMPUS
- Blood BDNF concentrations reflect brain-tissue BDNF levels across species
- (2010) Anders B. Klein et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Prefrontal 2 Subunit-Containing and 7 Nicotinic Acetylcholine Receptors Differentially Control Glutamatergic and Cholinergic Signaling
- (2010) V. Parikh et al. JOURNAL OF NEUROSCIENCE
- Adjunctive Risperidone for Partially Responsive People with Schizophrenia Treated with Clozapine
- (2010) Elaine Weiner et al. NEUROPSYCHOPHARMACOLOGY
- Minocycline Synergizes with N-Acetylcysteine and Improves Cognition and Memory Following Traumatic Brain Injury in Rats
- (2010) Samah G. Abdel Baki et al. PLoS One
- Axonal 7 nicotinic ACh receptors modulate presynaptic NMDA receptor expression and structural plasticity of glutamatergic presynaptic boutons
- (2010) H. Lin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cortical Kynurenine Pathway Metabolism: A Novel Target for Cognitive Enhancement in Schizophrenia
- (2010) I. Wonodi et al. SCHIZOPHRENIA BULLETIN
- A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia
- (2010) Akihiro Shiina et al. Annals of General Psychiatry
- Coupling of the NMDA receptor to neuroprotective and neurodestructive events
- (2009) Giles E. Hardingham BIOCHEMICAL SOCIETY TRANSACTIONS
- A 2-base pair deletion polymorphism in the partial duplication of the α7 nicotinic acetylcholine gene (CHRFAM7A) on chromosome 15q14 is associated with schizophrenia
- (2009) Melissa L. Sinkus et al. BRAIN RESEARCH
- Galantamine-ER For Cognitive Dysfunction In Bipolar Disorder and Correlation with Hippocampal Neuronal Viability: A Proof-of-Concept Study
- (2009) Dan V. Iosifescu et al. CNS Neuroscience & Therapeutics
- Decreased BDNF levels in CSF of drug-naive first-episode psychotic subjects: correlation with plasma BDNF and psychopathology
- (2009) Anilkumar Pillai et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Why Aren’t MAOIs Used More Often?
- (2009) Jan Fawcett JOURNAL OF CLINICAL PSYCHIATRY
- The dynamic effects of nicotine on the developing brain
- (2009) Jennifer B. Dwyer et al. PHARMACOLOGY & THERAPEUTICS
- Correlations and Discrepancies between Serum and Brain Tissue Levels of Neurotrophins after Electroconvulsive Treatment in Rats
- (2009) A. Sartorius et al. PHARMACOPSYCHIATRY
- Wayne Fenton, M.D.
- (2008) Ellen Stover et al. AMERICAN JOURNAL OF PSYCHIATRY
- N-Acetyl Cysteine as a Glutathione Precursor for Schizophrenia—A Double-Blind, Randomized, Placebo-Controlled Trial
- (2008) Michael Berk et al. BIOLOGICAL PSYCHIATRY
- Elevated Cerebrospinal Fluid Lactate Concentrations in Patients with Bipolar Disorder and Schizophrenia: Implications for the Mitochondrial Dysfunction Hypothesis
- (2008) William T. Regenold et al. BIOLOGICAL PSYCHIATRY
- Effects of memantine and galantamine given separately or in association, on memory and hippocampal neuronal loss after transient global cerebral ischemia in gerbils
- (2008) Silvia Lorrio et al. BRAIN RESEARCH
- A Randomized, Placebo-Controlled Study of Memantine as Adjunctive Treatment in Patients with Schizophrenia
- (2008) Jeffrey A Lieberman et al. NEUROPSYCHOPHARMACOLOGY
- Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia
- (2008) John E. Lisman et al. TRENDS IN NEUROSCIENCES
- Galantamine for the Treatment of Cognitive Impairments in People With Schizophrenia
- (2007) Robert W. Buchanan et al. AMERICAN JOURNAL OF PSYCHIATRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now